Labiotech.eu

News and Trends 27 Jun 2023

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

Actimed Therapeutics Ltd, a U.K.-based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, has raised more than £5 million ($6.4 million) in an over-subscribed Series A financing round. The investment will support the development of the Actimed pipeline, including S-pindolol benzoate, with preparations […]

June 27, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 27 Jun 2023

Laying the foundation for the future of personalized treatment?

In the evolving world of precision medicine, the need for methods that can measure biomolecules with supreme accuracy and specificity is paramount. Recognizing this, Yan Xu of the Graduate School of Engineering at Osaka Metropolitan University in Japan, and his international research team, say they have made a great stride in this direction. They have […]

June 27, 2023 - 2 minutesmins - By Jim Cornall

How to find lab space as a startup

June 27, 2023 - 7 minutesmins - By External Contributor

Best in Biotech 26 Jun 2023

Five animal health companies you should know about

The animal health market initially emerged because of the demand for a specific segment within biotech and pharma that focuses on improving the life of animals, including companion animals, such as dogs and cats, and farm animals, such as cattle and poultry. Now, there are lots of animal health companies trying to make a difference […]

June 26, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 26 Jun 2023

AbbVie takes step forward in Europe with migraine drug

AbbVie says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CMHP) has adopted a positive opinion recommending the approval of atogepant for the prophylaxis of migraine in adults who have four or more migraine days per month. If approved, AbbVie will be the only company to offer a once daily oral […]

June 26, 2023 - 4 minutesmins - By Jim Cornall

Best in Biotech 23 Jun 2023

Six biotech companies in South Korea you should know about

A major player in the machinery, electronics and telecommunications market, South Korea’s growing biotech industry has made headlines over the past few years. Home to hundreds of biopharmaceutical companies, the sector saw ₩2.8 trillion ($2.14 billion) worth of investments pour in, according to 2021 statistics. One of the largest contract drug developers, Samsung Biologics, headquartered […]

June 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 23 Jun 2023

New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results

NMD Pharma A/S, a clinical stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular disorders, has presented results from ESTABLISH1, an observational study of neuromuscular function in patients with the inherited neurological conditions Charcot-Marie-Tooth (CMT) types 1 and 2. The results were revealed in a poster presentation at the Peripheral Nerve Society Annual […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

Podcast 23 Jun 2023

Beyond Biotech podcast 51

This week, we look at biomarkers, among other topics, with founder and CEO of Sapient, Mo Jain. We also have an overview of the Lund Spring Symposium with Dan Larhammar, Thoas Fioretos, and Sander van Deventer. Sapient Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans through […]

June 23, 2023

News and Trends 23 Jun 2023

Breakthrough treatment for skin infections?

A research team led by Kelvin Yeung from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has designed a new microneedle patch that provides an effective non-antibiotic approach for the treatment of skin infections. The design engineered with ultrasound-responsive zinc-based metal-organic framework (MOF) […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

European Coalition for Access to Comprehensive Genomic Profiling launched

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, have launched the European Coalition for Access to Comprehensive Genomic Profiling (ECGP), to improve cancer care through increased routine clinical access and reimbursement of Comprehensive Genomic Profiling (CGP) in Europe. CGP is a method of testing tumors that […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

Sarepta gets approval for first gene therapy for Duchenne muscular dystrophy

Sarepta Therapeutics, Inc. has announced U.S. Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an Adeno-associated virus (AAV)-based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. This indication is approved under accelerated approval […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

SandboxAQ launches new division to boost drug development

After several years of stealth development, SandboxAQ has announced its bio-pharma molecular simulation division, AQBioSim, and some of its customers. The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer’s, Parkinson’s, and other conditions. The company is currently working with biopharma companies and university research labs, including AstraZeneca, Sanofi and […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

Laying the foundation for the future of personalized treatment?

How to find lab space as a startup

Five animal health companies you should know about

AbbVie takes step forward in Europe with migraine drug

Six biotech companies in South Korea you should know about

New disease characteristic seen as NMD Pharma reports Charcot-Marie-Tooth results

Beyond Biotech podcast 51

Breakthrough treatment for skin infections?

European Coalition for Access to Comprehensive Genomic Profiling launched

Sarepta gets approval for first gene therapy for Duchenne muscular dystrophy

SandboxAQ launches new division to boost drug development

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!